Do you need to know more about what we offer for each of our products?

Do you want to know more about LUCENTIS Access Solutions? To see what we offer, click here.

The information contained in this section of the site is for U.S. health care professionals only. Please click "OK" if you are a U.S. health care professional.

The link you selected will take you away from this site to one that is not owned or controlled by Genentech. Genentech is not part of the site. Nor does it control the content. Genentech does not guarantee the information on the page. Your use of third-party websites is at your own risk and is subject to the terms and conditions of use for such sites. 


Questions and Answers About LUCENTIS Access Solutions


If this is your first time working with LUCENTIS® Access Solutions - or even if you've worked with us before - you are bound to have some questions about how our programs work for treatment with LUCENTIS® (ranibizumab injection). We've assembled a list of questions we are asked most often and provided the answers you might need.

What is LUCENTIS Access Solutions?

We are a service provided by Genentech for LUCENTIS patients and their health care professionals. We help you in resolving specific coverage and reimbursement issues, as well as providing patient assistance for access to LUCENTIS and important information resources.


How do I contact LUCENTIS Access Solutions

The quickest way to contact us is by calling our toll-free telephone number at (866) 724-9394. Our toll-free fax number is (866) 724-9412. Our mailing address is:

LUCENTIS Access Solutions
1 DNA Way, Mail Stop #858a
South San Francisco, CA 94080-4990


When does LUCENTIS Access Solutions start helping with my patient's case?

We can start helping to connect your patient to LUCENTIS as soon as we receive the completed required forms. In addition, if the LUCENTIS specialty pharmacy (SP) your patient is referred to can't provide support, the case goes to LUCENTIS Access Solutions for further assistance.


Should I contact LUCENTIS Access Solutions about general questions about LUCENTIS?

No. LUCENTIS Access Solutions can answer questions only about access and reimbursement.


Does LUCENTIS Access Solutions bill claims?

No. LUCENTIS Access Solutions cannot provide any billing services for your practice.


When should I refer my patient to LUCENTIS Access Solutions for help?

At any point in the process of obtaining LUCENTIS for your patient - whether you've just decided to prescribe it for your patient, if you've submitted a prior authorization (PA) request to the insurer and LUCENTIS wasn't approved or if your patient has been on LUCENTIS but is now having insurance issues.


How do I refer my patient to LUCENTIS Access Solutions?

Please see How to Refer Patients to LUCENTIS Access Solutions for more information. 


Do I need to register my LUCENTIS patients with you before treatment begins?

No. There is no need to preregister a patient with us. However, you do need to enroll a patient for our help with issues of access and reimbursement. LUCENTIS Access Solutions is a voluntary program offered at no charge to you or your patients.


Why do LUCENTIS Access Solutions and specialty pharmacies ask for medical documentation?

We provide access and reimbursement support for a patient based on the patient's clinical situation and the insurer's coverage guidelines. Medical documentation is needed during prior authorization and/or the appeals process.


Can LUCENTIS Access Solutions assist with co-pay issues?

Yes. We can help with co-pay issues. We can explore alternative coverage options and available resources in the community to help with co-pays. We can refer the patient to an independent, non-profit organization offering assistance for people with wet age-related macular degeneration or macular edema following retinal vein occlusion. (We do not influence or control the operations of these organizations. Nor can we guarantee they will provide co-pay assistance.)


Is there assistance for uninsured patients who have been prescribed LUCENTIS?

The Genentech®Access to Care Foundation provides help for qualified patients. These include patients who are uninsured or whose health plans have denied payment for LUCENTIS. They must meet certain financial and medical requirements. 


Who is LUCENTIS for?

LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with Wet Age-Related Macular Degeneration (AMD) and Macular Edema Following Retinal Vein Occlusion (RVO).

What important safety information should I know about LUCENTIS?

LUCENTIS is a prescription medication given by injection into the eye, and it has side effects. Some LUCENTIS patients have had detached retinas and serious eye infections. LUCENTIS should not be used in patients who have an infection in or around the eye or are allergic to LUCENTIS or any of its ingredients. LUCENTIS patients have had increases in eye pressure within 1 hour of an injection. Serious side effects also include inflammation inside the eye, and rarely, problems related to the injection procedure, such as cataracts. Although not common, some LUCENTIS patients have had strokes or heart attacks. If your eye becomes red, sensitive to light, painful, or has a change in vision, you should call or visit your eye doctor right away. Ask your doctor if you have questions or want more information.

For additional safety information, please talk to your doctor and see the LUCENTIS full prescribing information.

LUCENTIS® is a registered trademark and the Access Solutions logo and the Access Solutions Treatment made possible logo are trademarks of Genentech USA, Inc.

© 2010 Genentech USA, Inc. All rights reserved. This site is intended for U.S. residents only.